Skip to content

Menu

Mayer Brown LLP logo
HomeAboutAt A GlanceOn point.MB MicrotalksResourcesWriting on the WallBooksContact
Free Writings & Perspectives logo
Home » MB Microtalk: COVID-related Non-GAAP Financial Measures

MB Microtalk: COVID-related Non-GAAP Financial Measures

By Melissa Pulgiano on April 19, 2021
Posted in COVID-19, SEC News

In this microtalk video, Laura Richman discusses the use by SEC registrants of non-GAAP financial measures involving COVID-19 adjustments.

Visit our MB Microtalk page for more topics and talks.

Print:
Email this postTweet this postLike this postShare this post on LinkedIn

Free Writings & Perspectives

News and Views on Securities Regulation and Capital Formation

We see what others don’t… Learn more

Editor

  • Anna T. Pinedo

What’s the Deal?

Topics

  • 20% rule
  • Accelerated Filer Definitions
  • Accounting Standards
  • Accredited Investors
  • AI
  • ATMs
  • Bank Notes
  • Basel Reforms
  • BDCs
  • Brexit
  • Broker-dealers
  • C&DIs
  • Capital Formation
  • CFTC
  • Class Actions
  • Comfort Letters
  • Commercial Paper
  • Communications
  • Connected & Autonomous Vehicles
  • Consent Solicitations
  • Convertible Bonds
  • Corporate Governance
  • Covered Bonds
  • COVID-19
  • Critical Audit Matters
  • Crowdfunding
  • Cybersecurity
  • D&O Insurance
  • Debt Offerings
  • Debt Tenders
  • Derivatives
  • Digital Assets
  • Direct Lending
  • Direct Listings
  • Disclosure Requirements
  • Diversity & Inclusion
  • Dodd-Frank
  • Due Diligence
  • EGCs
  • Electric Vehicles
  • Emerging Markets
  • ESG
  • Events
  • Exchange Act
  • Executive Compensation
  • Exempt Offerings
  • FAST Act
  • FDA
  • Financial Reporting
  • Financial Services
  • FINRA
  • Fintech
  • Follow-ons
  • Foreign Private Issuers
  • Funds
  • General Solicitation
  • Health Tech
  • Healthcare
  • High Yield Bonds
  • House Financial Services Committee
  • Human Capital
  • Impact Investing
  • Insurance
  • Insurtech
  • Investment Advisers Act
  • Investment Company Act
  • Investor Advisory Committee
  • Investor Relations
  • IPOs
  • JOBS Act
  • Liability Management
  • LIBOR
  • Life Sciences
  • Litigation Updates
  • M&A
  • Mezzanine/Pre-IPO Private Placements
  • MTN Programs
  • Nasdaq
  • NYSE Rules
  • Opportunity Zone Funds
  • Pending Legislation
  • PIPEs
  • Pre-Funded Warrants
  • Private Companies
  • Private Debt
  • Private Equity
  • Private Placements
  • Proxy Rules
  • Public Companies
  • Public Company Readiness
  • Public Policy
  • QIBs
  • Registered Direct Offerings
  • Regulation A
  • Regulation Best Interest
  • Regulation D
  • Regulation FD
  • Regulation S-K
  • Regulatory
  • REITs
  • Reporting Standards
  • Research
  • Resources
  • Restrictive Market
  • Rights Offerings
  • Rule 10b5-1
  • Rule 144A
  • Rule 506
  • SEC News
  • Securities Enforcement
  • Securities Litigation
  • Securities Regulation
  • Share Repurchases
  • Smaller Reporting Companies
  • Social Media
  • SPACs
  • Start-ups
  • State Securities
  • Stock Ownership
  • Structured Finance
  • Structured Products
  • SVB Receivership
  • Tax
  • Tech
  • Testing-the-Waters
  • Uncategorized
  • Unicorns
  • Up-C Structure
  • Venture Capital
  • Venture Exchanges
  • Volcker Rule
  • Voting Structures

Archives

Recent Updates

  • Upcoming Investor Advisory Committee Meeting
  • SEC Filing Fees
  • FINRA Update on Crypto Asset Activities
  • SDNY Issues Final Ruling on SEC v. Ripple
  • Qualifying Venture Capital Funds Inflation Adjustment

Blogroll

  • CLS Blue Sky Blog
  • Harvard Law School Forum on Corporate Governance and Financial Regulation
  • Jim Hamilton's World of Securities Regulation
  • Knowledge@Wharton
  • PLI’s The SEC Institute Blog
  • The Corporate Counsel

Stay Connected

RSS Twitter LinkedIn Facebook
Free Writings & Perspectives logo
Legal NoticesPrivacy Policy Cookie Preferences
© 2024, Mayer Brown LLP. All Rights Reserved.
Law blog design & platform by LexBlog LexBlog Logo